Ex Parte Morrison - Page 5


                   Appeal No. 2004-1112                                                                    Page 5                       
                   Application No. 09/829,707                                                                                           

                   public, and therefore not available as prior art under 35 U.S.C. § 102(a), until it                                  
                   issued as a patent.                                                                                                  
                           Since Rosner did not issue until after the filing date of the instant                                        
                   application, it does not qualify as prior art under § 102(a).  The correct statute for                               
                   applying a patent that was filed before, but issued after, a given application filing                                
                   date is 35 U.S.C. § 102(e).  See In re Lund, 376 F.2d 982, 988, 153 USPQ 625,                                        
                   630 (CCPA 1967) (“It is, of course, incontrovertible that a description of an                                        
                   invention of another in an application filed before an applicant's date of invention,                                
                   upon which application a patent is issued, constitutes a bar to the issuance of a                                    
                   valid patent for the same invention, Alexander Milburn Co. v. Davis-Bournonville                                     
                   Co., 270 U.S. 390, 46 S.Ct. 324, 70 L.Ed. 651 (1926), codified by § 102(e).”).  See                                  
                   also id. at 992 n.12, 153 USPQ 625, 633 n.12 (“Inasmuch as § 102(e) makes a                                          
                   description in a patent available as evidence of prior knowledge as of the effective                                 
                   filing date of the application on which the patent issues, it should be regarded as                                  
                   an exception to the general rule that prior knowledge must be public in order to                                     
                   defeat another’s patent rights.”).                                                                                   
                   2.  Bremer                                                                                                           
                           The examiner rejected claims 15-27 as anticipated by Bremer, on the                                          
                   basis that Bremer “discloses glucosidase and/or amylase inhibitors that can be                                       
                   manufactured as pharmaceutical compositions for the combined use with a                                              
                   lipase inhibitor.”  Examiner’s Answer, pages 4-5.  The examiner pointed out that                                     
                   Bremer suggests acarbose as one of the inhibitors that can be included in the                                        
                   disclosed compositions, and concluded that the “pharmaceutical composition that                                      





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007